市场调查报告书
商品编码
1452638
南美洲和中美洲家禽诊断市场预测至 2030 年 - 区域分析 - 按测试类型和疾病(禽沙门氏菌病、禽流感、新城疫、禽支原体病、传染性支气管炎等)South & Central America Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) |
南美洲和中美洲家禽诊断市场预计将从2022年的5,052万美元成长到2030年的1.0535亿美元。预计2022年至2030年CAGR为9.6%。
农场现场诊断家禽平台推动南美洲和中美洲家禽诊断市场
如今,在感染率较高的农场现场安装了简单的农场端分子诊断平台和补充监测软体,透过对家禽动物进行病毒和细菌病原体检测来遏制疾病传播。此外,家禽产业团队可以在短时间内成功开发出符合世界卫生组织 (WHO) 指南的便携式、电池供电、独立的诊断平台,以确保这些设备可以在农场的任何地方运行,从而消除了需要实验室结构、训练有素的人员和附加设备。此外,该设备的成本比同类商用设备低 95%,并根据具有同等标准的黄金标准设备进行了验证。因此,实施此类农场家禽疾病诊断平台将有助于农民透过早期发现和遏制来控制传染病、抗菌素抗药性(AMR)和人畜共通病原体的传播。
南美洲和中美洲家禽诊断市场概述
南美洲和中美洲家禽诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。该地区的市场成长主要是由于高致病性禽流感(HPAI)发病率的增加以及为提高食品品质而对家禽诊断的需求不断增长。泛美卫生组织(PAHO)和世界卫生组织(WHO)已确认高致病性禽流感在南美洲和中美洲的玻利维亚、哥伦比亚、哥斯大黎加、秘鲁蔓延。
南美洲和中美洲家禽诊断市场收入及 2030 年预测(百万美元)
南美洲和中美洲家禽诊断市场细分
南美洲和中美洲家禽诊断市场分为测试类型、疾病和国家。
根据测试类型,南美洲和中美洲家禽诊断市场分为酵素连结免疫吸附测定(ELISA)测试、聚合酶链反应(PCR)测试、血凝抑制(HI)等。 2022 年,酵素连结免疫吸附测定 (ELISA) 测试领域在南美洲和中美洲家禽诊断市场中占据最大份额。
疾病方面,南美洲及中美洲家禽诊断市场分为禽流感、传染性支气管炎、禽沙门氏菌病、新城疫、禽支原体病等。 2022 年,禽支原体病细分市场在南美洲和中美洲家禽诊断市场中占据最大份额。
依国家划分,南美洲和中美洲家禽诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年,巴西主导南美洲和中美洲家禽诊断市场。
Thermo Fisher Scientific Inc、Idex Laboratories Inc、Qiagen NV、Eurofins Scientific SE、Boehringer Ingelheim International GmbH、Zoetis Inc 和 BioCheck BV 是南美洲和中美洲家禽诊断市场上的一些领先公司。
The South & Central America poultry diagnostic market is expected to grow from US$ 50.52 million in 2022 to US$ 105.35 million by 2030. It is estimated to grow at a CAGR of 9.6% from 2022 to 2030.
Farm-Side Diagnostic Poultry Platform Fuel South & Central America Poultry Diagnostic Market
Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team can successfully develop a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.
South & Central America Poultry Diagnostic Market Overview
The South & Central America Poultry Diagnostics Market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in the region is mainly driven by increasing incidence of highly pathogenic avian influenza (HPAI) and rising demand for poultry diagnostics to enhance the quality of food products. The Pan American Health Organization (PAHO) and the World Health Organization (WHO) have confirmed the spread of highly pathogenic avian influenza across Bolivia, Colombia, Costa Rica, Peru, in South & Central America.
South & Central America Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)
South & Central America poultry diagnostic market Segmentation
The South & Central America poultry diagnostic market is segmented into test type, disease, and country.
Based on test type, the South & Central America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the South & Central America poultry diagnostic market in 2022.
In terms of disease, the South & Central America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian mycoplasmosis segment held the largest share of the South & Central America poultry diagnostic market in 2022.
By country, the South & Central America poultry diagnostic market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America poultry diagnostic market in 2022.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, and BioCheck BV are some of the leading companies operating in the South & Central America poultry diagnostic market.